Offline mode

alpha2,6-Sialyltransferase ELISA

Catalog no.JP27762
Regulatory Status
RUO
Kit size
12 x 8
Method
ELISA
Incubation time
1 x 60 min, 2 x 30 min
Standard range
1.09 - 70 ng/mL
Specimen / Volumes
100 µL serum, EDTA-plasma, cell culture supernatant
Substrate / isotope
TMB 450 nm

One of the major enzymes involved in Alzheimer's Disease (AD) pathology is the so-called β-secretase, also known as BACE1. Inhibition of BACE1 is thought to be a useful drug target for the treatment of AD. More recently it was discovered that a specific glycosyltransferase involved in the biosynthesis of sugar chains, the α2,6-Sialyltransferase serves also as a substrate for BACE1. At the same time also the cleavage site on the α2,6-Sialyltransferase was identified in a rat model. This assay allows the measurement of human, rat and mouse α2,6-Sialyltransferase Separate control set available on request

Our Product Families

Our comprehensive immunoassay portfolio includes a number of specialty diagnostic immunoassays for endocrinology, immunology and autoimmunity, as well as for diagnosis of multiple infectious diseases. We are pioneers and market leaders in saliva diagnostics, with over 40 years of experience supplying a broad portfolio of luminescence- and ELISA-based tests, including our highly acclaimed HMGB1 and MuSK-Ab ELISAs.

And as experts in laboratory automation, we can support our customers with the protocols for open ELISA platforms, such as the Freedom EVOlyzer or Thunderbolt®.

All products are only available for sale to laboratory professionals and may not be available in all countries. Availability and regulatory status may vary across regions depending on local country-specific registration. Please always read and follow the instructions for use. 

All of our assays have been designed and manufactured to meet the highest global regulatory requirements and quality standards. Tecan is certified under ISO 9001:2015, ISO 13485:2016 and is audited by a notified body according to Medical Device Single Audit Program (MDSAP).

Image on background

This is who we are.

As part of the Tecan Group, we have a leading market position in diagnostics and research, with over 40 years of experience in the development, manufacture and supply of enzyme-, radiolabel- and luminescence-based immunoassays.

Our range of high-quality immunoassays is supported by a diverse portfolio of automated solutions, making us the perfect partner for you and your customers.

Happy to help.

At Tecan, we are driven to improve people’s lives and health.